®
The WIOL-CF ® (Gelmed International, Kamenne Zehrovice, Czech Republic) is a hydrogel (WiGEL) polyfocal full-optics intraocular lens (IOL) that is suitable for cataract patients who want good far, intermediate, and near vision after surgery. [1] It has a relatively large optic size (9 mm) without haptic. The unique design of WIOL-CF ® IOL may result in positional instability, and dislocation of them has been described in recent reports. [2, 3] Notably, the positional instability of WIOL-CF ® IOLs has been reported to exhibit a unique pattern, with a preceding tilt of the IOL, and a stretched capsular bag, followed by posterior capsule rupture. Herein, we describe a case of WIOL-CF ® IOL-capsular bag complex dislocation without trauma that differed from the previously reported pattern, and review the relevant literature.
Case Report
A 56-year-old man was referred to our hospital with the chief complaint of sudden-onset visual disturbance in his left eye without trauma. He had undergone uneventful phacoemulsification with WIOL-CF ® IOL implantation in the left eye at the local ophthalmic clinic 7 years prior. At that time, the preoperative uncorrected visual acuity (UCVA) at far distance was 20/60 (OS, oculus sinister) by Snellen chart and manifest refraction (MR) was not assessed due to crystalline lens opacity. Implantation of WIOL-CF ® IOL was performed with 3-mm sized temporal clear corneal incision and without any intra-operative complication. The postoperative UCVA at far distance was 20/20 (OS), and remained stable until the event of a sudden visual loss. 
Discussion
The incidence of late in-the-bag spontaneous IOL dislocation is increasing, and it is usually diagnosed 6 to 9 years after uneventful cataract surgery. [4, 5] While potential mechanisms associated with these dislocations are not widely agreed upon, zonular weakness secondary to capsular contraction is believed to be one of the most common causes.
[6] WIOL-CF ® IOLs have a high water content (42%), they exhibit high biocompatibility and permeability, and their negatively charged surface confers resistance to protein deposits, cell attachment, opacification of the posterior capsule, and adhesion to surrounding tissues.
[7]
In addition, capsular contraction is minimal because it has no haptic. Therefore, WIOL-CF ® IOLs are thought to be unlikely to undergo in-the-bag dislocation.
It was recently reported that WIOL-CF
® IOL dislocation has a consistent pattern.
[2] The proposed process of WIOL-CF ® IOL dislocation is that first the IOL tilts forward and downward, then the anterior surface of the IOL touches the superior iris (iris atrophy), and the posterior surface of the IOL stretches the inferior posterior capsule and zonules, then lastly, the inferior posterior capsule ruptures and the IOL dislocates into the posterior segment. In the current case however, iris atrophy was not apparent at the initial visit, and the dislocated IOL was well-centered in the capsular bag without any tilt. The reason for zonular dialysis in the present case was unclear, because there was no history of trauma, but the unilateral cataract in a patient of relatively young age suggests that the left eye may have been subjected to unrecognized or repeated minor trauma. In a study conducted in Japan, [8] the second most common potentially predisposing condition in late in-the-bag IOL dislocations was habitual eye rubbing or tapping. The patient was an oriental melon farmer; he usually bends forward and lifts heavy boxes. Consequently, such activities would have resulted in severe IOP fluctuations.
[9] However, the relationship between late in-the-bag dislocation and the IOP fluctuations is uncertain and therefore, further studies are required. The present patient did not have any known conditions potentially predisposing him to IOL dislocation such as long axial length, pseudoexfoliation syndrome, or ocular allergy. One review article mentioned that only 90% of late IOL-capsular bag complex dislocation showed certain zonular weakness preoperatively.
[6] It is possible that there was a degree of zonular weakness that was not detectable via slit-lamp examination, and that the comparatively heavy WIOL-CF ® IOL exacerbated that weakness, ultimately resulting in in-the-bag dislocation. The dislocated WIOL-CF ® IOL cannot be fixated to the sclera due to the absence of haptic and therefore, explantation and exchange with a foldable acrylic single-piece IOL are required.
Conclusion
In conclusion, WIOL-CF ® IOLs may undergo in-the-bag dislocation without trauma, like other types of IOLs.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest. Increased intraocular pressure (IOP) is the most prominent cause responsible for the development of glaucoma, but there are many other risk factors also which are involved in the pathogenesis of glaucoma, including structural abnormalities and functional dysregulation of the vasculature supplying the optic nerve and the surrounding retinal tissue that also contribute for causation of glaucoma.
[1] Hypertriglyceridemia is one such metabolic factor, it causes vascular dysfunction that can further lead to glaucoma.
[2] So, a thorough ocular and systemic examination can help us to treat the patient rationally.
Case Report
A 16-year-old boy was referred to our outpatient department. His chief complaints were loss of vision and redness in the right eye associated with headaches since 5 months. Patient also gave history of gradual increase in the size of right eye since 5 months. There was no gross anomaly detected on general examination. He had undergone a whole spectrum of systemic investigations including brain MRI and everything had turned out to be negative. There was one red flag sign in the battery of investigations that had been done. His triglyceride level was 679 mg/dl, which was abnormally high for his age group and he was taking lipid lowering treatment for the same (Tablet Lipaglin OD for 3 months) advised by the physician.
His ocular examination showed best corrected visual acuity of hand movement close to face in the right eye and 6/9 in the left eye. On slit lamp examinations, right eye had diffuse conjunctival congestion, mild corneal haze, normal anterior chamber depth, relative afferent pupillary defect, and small twigs of iris neovascularization in pupillary margin in 2'o clock hours. Left eye anterior segment was within normal limits, with a clear cornea and reacting pupil. Lens was clear in both the eyes. IOPby Goldmann's Applanation tonometer was 54 mmHg in right eye and 15 mmHg in left eye. Gonioscopy revealed open angles up to scleral spur in both eyes. Fundus examination with 90D lens showed glaucomatous optic atrophy with cup to disc ratio of 0.9:1 (disc pallor) in the right eye [ Fig. 1 ] and 0.3:1 in the left eye, with normal blood vessels and bright foveal reflex. He was using following eye drops: brimonidine and brinzolamide combination BD, timolol BD and tablet acetazolamide SR BD, which was prescribed to him 2 days ago elsewhere. We added liquid glycerol 1 oz BD.
At 1 week follow-up, the pressure in right eye was 32 mmHg and left eye was 16 mmHg, and the neovascularization had resolved. He was intolerant to systemic antiglaucoma medications. The IOP was not under control with topical antiglaucoma treatment alone, we advised to go for right eye trabeculectomy with mitomycin C. The surgery in the right eye was done uneventfully. On first postoperative week, right eye IOP was 10 mmHg with a well-formed anterior chamber and good functioning bleb [ Fig. 2] . Because of discontinuation of systemic antiglaucoma medications, the left eye IOP had increased to 34 mmHg and he was prescribed eye drops: timolol BD, brimolol, and brimonidine combination BD and bimatoprost HS. Two weeks after giving maximum topical antiglaucoma treatment, the pressure of left eye was still 32 mmHg. This was a challenging situation for us as the left eye was the only seeing eye, IOP uncontrolled by topical antiglaucoma drugs, and the patient was intolerant to systemic medication.
Since trabeculectomy with MMC showed good response in the right eye, we performed the same procedure in the left eye. Seven days later, the inIOP in the right eye was 10 mmHg and
